149 related articles for article (PubMed ID: 35307354)
1. Diffuse gastric cancer: Emerging mechanisms of tumor initiation and progression.
Monster JL; Kemp LJS; Gloerich M; van der Post RS
Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188719. PubMed ID: 35307354
[TBL] [Abstract][Full Text] [Related]
2. Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer.
Shimada S; Mimata A; Sekine M; Mogushi K; Akiyama Y; Fukamachi H; Jonkers J; Tanaka H; Eishi Y; Yuasa Y
Gut; 2012 Mar; 61(3):344-53. PubMed ID: 21865403
[TBL] [Abstract][Full Text] [Related]
3. Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer.
Humar B; Fukuzawa R; Blair V; Dunbier A; More H; Charlton A; Yang HK; Kim WH; Reeve AE; Martin I; Guilford P
Cancer Res; 2007 Mar; 67(6):2480-9. PubMed ID: 17363565
[TBL] [Abstract][Full Text] [Related]
4. Cell division-dependent dissemination following E-cadherin loss underlies initiation of diffuse-type gastric cancer.
Monster JL; Kemp LJ; Busslinger GA; Vliem MJ; Derks LL; Staes AA; Bisseling TM; Clevers H; van der Post RS; Gloerich M
J Pathol; 2024 Jun; 263(2):226-241. PubMed ID: 38572612
[TBL] [Abstract][Full Text] [Related]
5. Histological and mutational profile of diffuse gastric cancer: current knowledge and future challenges.
Garcia-Pelaez J; Barbosa-Matos R; Gullo I; Carneiro F; Oliveira C
Mol Oncol; 2021 Nov; 15(11):2841-2867. PubMed ID: 33724653
[TBL] [Abstract][Full Text] [Related]
6. Multi-omics analysis identifies pathways and genes involved in diffuse-type gastric carcinogenesis induced by E-cadherin, p53, and Smad4 loss in mice.
Park JW; Kim MS; Voon DC; Kim SJ; Bae J; Mun DG; Ko SI; Kim HK; Lee SW; Kim DY
Mol Carcinog; 2018 Jul; 57(7):947-954. PubMed ID: 29528141
[TBL] [Abstract][Full Text] [Related]
7. In vivo CRISPR-Cas9 knockout screening using quantitative PCR identifies thymosin beta-4 X-linked that promotes diffuse-type gastric cancer metastasis.
An HW; Kim SY; Kwon JW; Seok SH; Woo SH; Kim DY; Park JW
Mol Carcinog; 2021 Sep; 60(9):597-606. PubMed ID: 34081824
[TBL] [Abstract][Full Text] [Related]
8. E-cadherin is a biomarker for ferroptosis sensitivity in diffuse gastric cancer.
Minikes AM; Song Y; Feng Y; Yoon C; Yoon SS; Jiang X
Oncogene; 2023 Mar; 42(11):848-857. PubMed ID: 36717701
[TBL] [Abstract][Full Text] [Related]
9. IL-1β derived from mixed-polarized macrophages activates fibroblasts and synergistically forms a cancer-promoting microenvironment.
Zhang J; Fu L; Yasuda-Yoshihara N; Yonemura A; Wei F; Bu L; Hu X; Akiyama T; Kitamura F; Yasuda T; Semba T; Uchihara T; Itoyama R; Yamashita K; Eto K; Iwagami S; Yashiro M; Komohara Y; Baba H; Ishimoto T
Gastric Cancer; 2023 Mar; 26(2):187-202. PubMed ID: 36513910
[TBL] [Abstract][Full Text] [Related]
10. Histopathological, Molecular, and Genetic Profile of Hereditary Diffuse Gastric Cancer: Current Knowledge and Challenges for the Future.
van der Post RS; Gullo I; Oliveira C; Tang LH; Grabsch HI; O'Donovan M; Fitzgerald RC; van Krieken H; Carneiro F
Adv Exp Med Biol; 2016; 908():371-91. PubMed ID: 27573781
[TBL] [Abstract][Full Text] [Related]
11. CXCL1-Chemokine (C-X-C Motif) Receptor 2 Signaling Stimulates the Recruitment of Bone Marrow-Derived Mesenchymal Cells into Diffuse-Type Gastric Cancer Stroma.
Kasashima H; Yashiro M; Nakamae H; Kitayama K; Masuda G; Kinoshita H; Fukuoka T; Hasegawa T; Nakane T; Hino M; Hirakawa K; Ohira M
Am J Pathol; 2016 Nov; 186(11):3028-3039. PubMed ID: 27742059
[TBL] [Abstract][Full Text] [Related]
12. The keratin 17/YAP/IL6 axis contributes to E-cadherin loss and aggressiveness of diffuse gastric cancer.
Li M; Rao X; Cui Y; Zhang L; Li X; Wang B; Zheng Y; Teng L; Zhou T; Zhuo W
Oncogene; 2022 Feb; 41(6):770-781. PubMed ID: 34845376
[TBL] [Abstract][Full Text] [Related]
13. Indolent feature of Helicobacter pylori-uninfected intramucosal signet ring cell carcinomas with CDH1 mutations.
Nikaido M; Kakiuchi N; Miyamoto S; Hirano T; Takeuchi Y; Funakoshi T; Yokoyama A; Ogasawara T; Yamamoto Y; Yamada A; Setoyama T; Shimizu T; Kato Y; Uose S; Sakurai T; Minamiguchi S; Obama K; Sakai Y; Muto M; Chiba T; Ogawa S; Seno H
Gastric Cancer; 2021 Sep; 24(5):1102-1114. PubMed ID: 33961152
[TBL] [Abstract][Full Text] [Related]
14. Circulating microRNAs as biomarkers for early detection of diffuse-type gastric cancer using a mouse model.
Rotkrua P; Shimada S; Mogushi K; Akiyama Y; Tanaka H; Yuasa Y
Br J Cancer; 2013 Mar; 108(4):932-40. PubMed ID: 23385731
[TBL] [Abstract][Full Text] [Related]
15. Relationships of tumor differentiation and immune infiltration in gastric cancers revealed by single-cell RNA-seq analyses.
Zhou X; Yang J; Lu Y; Ma Y; Meng Y; Li Q; Gao J; Jiang Z; Guo L; Wang W; Liu Y; Wen L; Kai M; Fu W; Tang F
Cell Mol Life Sci; 2023 Feb; 80(2):57. PubMed ID: 36729271
[TBL] [Abstract][Full Text] [Related]
16. Plasma microRNA-103, microRNA-107, and microRNA-194 levels are not biomarkers for human diffuse gastric cancer.
Oze I; Shimada S; Nagasaki H; Akiyama Y; Watanabe M; Yatabe Y; Matsuo K; Yuasa Y
J Cancer Res Clin Oncol; 2017 Mar; 143(3):551-554. PubMed ID: 27909811
[TBL] [Abstract][Full Text] [Related]
17. CDH1 somatic alterations in Mexican patients with diffuse and mixed sporadic gastric cancer.
Bustos-Carpinteyro AR; Oliveira C; Sousa A; Oliveira P; Pinheiro H; Carvalho J; Magaña-Torres MT; Flores-Miramontes MG; Aguilar-Lemarroy A; Jave-Suárez LF; Peregrina-Sandoval J; Cruz-Ramos JA; Sánchez-López JY
BMC Cancer; 2019 Jan; 19(1):69. PubMed ID: 30642281
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
Jacobs MF; Dust H; Koeppe E; Wong S; Mulholland M; Choi EY; Appelman H; Stoffel EM
Gastroenterology; 2019 Jul; 157(1):87-96. PubMed ID: 30935944
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia upregulates adhesion ability to peritoneum through a transforming growth factor-beta-dependent mechanism in diffuse-type gastric cancer cells.
Noda S; Yashiro M; Nshii T; Hirakawa K
Eur J Cancer; 2010 Mar; 46(5):995-1005. PubMed ID: 20144860
[TBL] [Abstract][Full Text] [Related]
20. Profiling Kinase Activities for Precision Oncology in Diffuse Gastric Cancer.
Singh S; Parthasarathi KTS; Bhat MY; Gopal C; Sharma J; Pandey A
OMICS; 2024 Feb; 28(2):76-89. PubMed ID: 38271566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
